According to the Ayurvedic principles, a drug or therapy should not be only having pacifying effect on disease, but also it must not create any adverse effect or complication. A drug should not be only efficacious, but also easily available. Taking all these points into consideration, Dantashodhan churna (DC) was selected in the present study for the management of Danta Sharkara which has been mentioned by Sushruta. The present study was aimed at setting up a standard profile of Dantashodhan churna which was prepared using pharmacognostically authenticated raw drugs followed by subjecting it to detailed pharmacognostical and physicochemical analysis as per standard protocol. The observations were systematically recorded. Pharmacognostical findings of raw drugs (Parenchyma cells with starch grains, brown content, black debris, prismatic crystal, scleroids, perisperm cells, epidermal cells, aleurone grains, stone cells with stains, starch grain etc.) confirm the authentication of ingredients present in the finished product. Organoleptic features of DC made out of the crude drugs were within the standard range as mentioned in the classic. The pH value of DC was 7, loss on drying was 9.83% w/w, ash value was 5.6% w/w, water-soluble extract was 57% w/w, methanol soluble extraction was 12.9% w/w and high performance thin layer chromatography (HPTLC) at 254 nm and 366 nm resulted into 7 and 5 spots respectively.
Loading....